VOQP Stock Chart & Stats
$0.01
$0.00(0.00%)
At close: 4:00 PM EST
$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.01 - $0.01
Previous CloseN/A
Volume24.00
Average Volume (3M)0.00
Market Cap
$5.00
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding5,462,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.00
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
VOQP FAQ
What was Vioquest Pharmaceuticals Inc’s price range in the past 12 months?
Vioquest Pharmaceuticals Inc lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.
What is Vioquest Pharmaceuticals Inc’s market cap?
Vioquest Pharmaceuticals Inc’s market cap is $5.00.
When is Vioquest Pharmaceuticals Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Vioquest Pharmaceuticals Inc’s earnings last quarter?
Currently, no data Available
Is Vioquest Pharmaceuticals Inc overvalued?
According to Wall Street analysts Vioquest Pharmaceuticals Inc’s price is currently Overvalued.
Does Vioquest Pharmaceuticals Inc pay dividends?
Vioquest Pharmaceuticals Inc does not currently pay dividends.
What is Vioquest Pharmaceuticals Inc’s EPS estimate?
Vioquest Pharmaceuticals Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Vioquest Pharmaceuticals Inc have?
Vioquest Pharmaceuticals Inc has 5,462,000 shares outstanding.
What happened to Vioquest Pharmaceuticals Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Vioquest Pharmaceuticals Inc?
Currently, no hedge funds are holding shares in VOQP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Vioquest Pharmaceuticals Inc
VioQuest Pharmaceuticals, Inc. is a biopharmaceutical entity that concentrates on obtaining, developing, and marketing drug therapies in clinical stages, specifically targeting oncology and infectious diseases. Its primary product, Xyfid, is currently being advanced for both the management and prevention of hand-foot syndrome. The company's pipeline also features VQD-002, a nucleoside analog presently in Phase I clinical trials for cancer treatment. Another key compound is Lenocta, a small molecule designed to inhibit various protein tyrosine phosphatases, which is progressing through Phase IIa clinical studies for indications like melanoma, renal cell carcinoma, and other solid tumors. Beyond its therapeutic drug development, VioQuest Pharmaceuticals offers chiral products, specialized technology, and bespoke synthesis development services. These services are provided to pharmaceutical and fine chemical companies at different stages of their product lifecycles. The firm was established in 2000 and operates from its corporate headquarters in Basking Ridge, New Jersey.